日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.

胰腺癌特有的隐蔽抗原是 T 细胞识别的目标

Ely Zackery A, Kulstad Zachary J, Gunaydin Gurcan, Addepalli Sudarsana, Verzani Eva K, Casarrubios Marta, Clauser Karl R, Wang Xilin, Lippincott Isabelle E, Louvet Cedric, Schmitt Thomas, Kapner Kevin S, Agus Miles P, Hennessey Connor J, Cleary James M, Hadrup Sine R, Klaeger Susan, Su Jennifer, Jaeger Alex M, Wolpin Brian M, Raghavan Srivatsan, Smith Eric L, Greenberg Philip D, Aguirre Andrew J, Abelin Jennifer G, Carr Steven A, Jacks Tyler, Freed-Pastor William A

Integrative genomic identification of therapeutic targets for pancreatic cancer

整合基因组学方法鉴定胰腺癌治疗靶点

Guo, Jimmy A; Gong, Dennis; Evans, Kyle; Takahashi, Kazuki; Jambhale, Ananya D; Shiau, Carina; Yu, Patrick; Wang, Steven; Wu, Wenbo W; Chugh, Seema; Kapner, Kevin S; Dilly, Julien; Zhao, Daniel; Chen, Peter; Smith, Eric L; Mancias, Joseph D; Vazquez, Francisca; Singh, Harshabad; Hwang, William L; Aguirre, Andrew J

Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer

胰腺癌经典型和基底型转录亚型的临床和基因组特征

Singh, Harshabad; Xiu, Joanne; Kapner, Kevin S; Yuan, Chen; Narayan, Raja R; Oberley, Matthew; Farrell, Alex; Surana, Rishi; Huffman, Brandon M; Perez, Kimberly; Cleary, James M; Jordan, Alexander C; Dias Costa, Andressa; Williams, Hannah L; Raghavan, Srivatsan; Weinberg, Benjamin; Pishvaian, Michael J; Shroff, Rachna T; Goel, Sanjay; Dougan, Stephanie K; Nowak, Jonathan A; Spetzler, David; Sledge, George; Wolpin, Brian M; Aguirre, Andrew J

Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity

空间分辨单细胞分析胰腺癌表达亚型揭示共表达表型和广泛的肿瘤内异质性

Williams, Hannah L; Dias Costa, Andressa; Zhang, Jinming; Raghavan, Srivatsan; Winter, Peter S; Kapner, Kevin S; Ginebaugh, Scott P; Väyrynen, Sara A; Väyrynen, Juha P; Yuan, Chen; Navia, Andrew W; Wang, Junning; Yang, Annan; Bosse, Timothy L; Kalekar, Radha L; Lowder, Kristen E; Lau, Mai Chan; Elganainy, Dalia; Morales-Oyarvide, Vicente; Rubinson, Douglas A; Singh, Harshabad; Perez, Kimberly; Cleary, James M; Clancy, Thomas E; Wang, Jiping; Mancias, Joseph D; Brais, Lauren K; Hill, Emma R; Kozak, Margaret M; Linehan, David C; Dunne, Richard F; Chang, Daniel T; Koong, Albert C; Hezel, Aram F; Hahn, William C; Shalek, Alex K; Aguirre, Andrew J; Nowak, Jonathan A; Wolpin, Brian M

Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

在 NRAS 突变肿瘤患者中,比美替尼治疗 NRAS 12/13 密码子和 61 密码子突变癌症的疗效存在差异(NCI-MATCH II 期试验)

Cleary, James M; Wang, Victoria; Heist, Rebecca S; Kopetz, E Scott; Mitchell, Edith P; Zwiebel, James A; Kapner, Kevin S; Chen, Helen X; Li, Shuli; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Meric-Bernstam, Funda; Dillmon, Melissa S; Williams, P Mickey; Hamilton, Stanley R; Conley, Barbara A; Aguirre, Andrew J; O'Dwyer, Peter J; Harris, Lyndsay N; Arteaga, Carlos L; Chen, Alice P; Flaherty, Keith T